240 related articles for article (PubMed ID: 17062432)
1. Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.
Cinelli M; Guiducci S; Del Rosso A; Pignone A; Del Rosso M; Fibbi G; Serratì S; Gabrielli A; Giacomelli R; Piccardi N; Matucci Cerinic M
Scand J Rheumatol; 2006; 35(5):346-50. PubMed ID: 17062432
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
Cho ML; Jung YO; Moon YM; Min SY; Yoon CH; Lee SH; Park SH; Cho CS; Jue DM; Kim HY
Immunol Lett; 2006 Mar; 103(2):159-66. PubMed ID: 16368150
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
[TBL] [Abstract][Full Text] [Related]
6. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
[TBL] [Abstract][Full Text] [Related]
7. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
[TBL] [Abstract][Full Text] [Related]
8. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M
Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
Kitano M; Hla T; Sekiguchi M; Kawahito Y; Yoshimura R; Miyazawa K; Iwasaki T; Sano H; Saba JD; Tam YY
Arthritis Rheum; 2006 Mar; 54(3):742-53. PubMed ID: 16508938
[TBL] [Abstract][Full Text] [Related]
13. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
[TBL] [Abstract][Full Text] [Related]
14. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
[TBL] [Abstract][Full Text] [Related]
15. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of the new antirheumatic drug KE-298 on TNF alpha-induced production of matrix metalloproteinases but not of tissue inhibitor-1 of metalloproteinases in human rheumatoid synoviocytes.
Takahashi S; Inoue T; Higaki M; Mizushima Y
Drugs Exp Clin Res; 1998; 24(2):67-71. PubMed ID: 9675546
[TBL] [Abstract][Full Text] [Related]
17. Expression and extracellular release of Trx80, the truncated form of thioredoxin, by TNF-alpha- and IL-1beta-stimulated human synoviocytes from patients with rheumatoid arthritis.
Lemarechal H; Anract P; Beaudeux JL; Bonnefont-Rousselot D; Ekindjian OG; Borderie D
Clin Sci (Lond); 2007 Aug; 113(3):149-55. PubMed ID: 17447898
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.
Jackson JR; Minton JA; Ho ML; Wei N; Winkler JD
J Rheumatol; 1997 Jul; 24(7):1253-9. PubMed ID: 9228120
[TBL] [Abstract][Full Text] [Related]
19. IL-17 and tumour necrosis factor α combination induces a HIF-1α-dependent invasive phenotype in synoviocytes.
Hot A; Zrioual S; Lenief V; Miossec P
Ann Rheum Dis; 2012 Aug; 71(8):1393-401. PubMed ID: 22532631
[TBL] [Abstract][Full Text] [Related]
20. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
Raychaudhuri SP; Raychaudhuri SK
Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
